A pilot study of 40 sepsis patients found that fecal microbiota transplantation (FMT) significantly restored gut bacterial diversity within two weeks, while probiotics showed minimal benefit. According to Gram Research analysis, FMT increased beneficial bacteria and reduced harmful bacteria by shifting the gut microbiome toward a healthier composition, suggesting it may improve recovery in critically ill patients treated with strong antibiotics.
When critically ill sepsis patients receive strong antibiotics to fight infection, these lifesaving drugs also kill the good bacteria in their gut, causing serious imbalance. Researchers tested whether fecal microbiota transplantation (FMT)—transferring healthy gut bacteria from a donor—or probiotics could restore the gut’s bacterial community better than antibiotics alone. In a pilot study of 40 sepsis patients, FMT significantly restored gut diversity and reduced harmful bacteria within two weeks, while probiotics showed minimal benefit. According to Gram Research analysis, this early evidence suggests FMT may help critically ill patients recover better after antibiotic treatment, though larger studies are needed to confirm these findings.
Key Statistics
A 2026 pilot randomized controlled trial of 40 sepsis patients found that fecal microbiota transplantation significantly increased gut bacterial diversity (Chao1 index p = 0.0125) compared to antibiotics alone or antibiotics plus probiotics after two weeks of treatment.
In a 2026 study of critically ill sepsis patients, FMT reduced the pathogenic potential of gut microbiota by 22% (p = 0.021) and increased beneficial Bacteroides bacteria while reducing harmful Enterobacteriaceae, whereas probiotics showed no significant improvement.
A 2026 pilot trial demonstrated that fecal microbiota transplantation successfully shifted recipient gut microbiomes toward donor bacterial profiles in sepsis patients, with genetic analysis confirming transplanted bacteria established and thrived despite ongoing antibiotic treatment.
The Quick Take
- What they studied: Whether fecal microbiota transplantation (FMT) or probiotics could better restore healthy gut bacteria in sepsis patients who received strong antibiotics that killed their beneficial bacteria.
- Who participated: 40 critically ill sepsis patients in an intensive care setting. They were divided into three groups: 20 received antibiotics only (control), 10 received antibiotics plus probiotics for one week, and 10 received antibiotics plus FMT for one week.
- Key finding: After two weeks, patients who received FMT had significantly more diverse and healthier gut bacteria compared to the other groups. FMT increased beneficial Bacteroides bacteria and reduced harmful Enterobacteriaceae, with statistical significance (p = 0.0125 for diversity measures).
- What it means for you: If you or a loved one is hospitalized with sepsis requiring strong antibiotics, FMT may help restore gut health faster than probiotics alone. However, this is early-stage research with a small group, so talk with your doctor before considering FMT as part of sepsis treatment.
The Research Details
This was a pilot randomized controlled trial, which means researchers randomly assigned patients to different treatment groups to compare results fairly. The study included 40 sepsis patients at a single hospital who were all receiving broad-spectrum antibiotics (strong antibiotics that kill many types of bacteria). Patients were split into three groups: a control group receiving only antibiotics, a probiotics group receiving antibiotics plus probiotic supplements for one week, and an FMT group receiving antibiotics plus fecal microbiota transplantation for one week.
Researchers measured gut bacteria using advanced genetic testing (16S rDNA sequencing), which identifies which bacteria are present and in what amounts. They also measured inflammatory markers—chemicals in the blood that show how much inflammation is happening in the body. Measurements were taken at the start, after one week, and after two weeks.
Fecal microbiota transplantation involves taking stool from a healthy donor and transferring it into the patient’s gut, essentially repopulating their intestines with beneficial bacteria. Probiotics are supplements containing live beneficial bacteria. The study compared how well each approach restored the gut’s bacterial community after antibiotics had disrupted it.
This research approach matters because sepsis is a life-threatening condition where antibiotics are essential, but they cause serious damage to the gut’s bacterial ecosystem. Understanding which restoration method works best could improve recovery and reduce complications in critically ill patients. A pilot study like this is the right first step before investing in larger, more expensive trials.
This is a pilot study with a small sample size (40 patients), which means results are preliminary and need confirmation in larger studies. The study was well-designed with random assignment to groups, which reduces bias. The use of genetic sequencing to identify bacteria is objective and reliable. However, the study was conducted at a single hospital, which may limit how well results apply to other settings. The short treatment period (one week) and follow-up (two weeks) mean we don’t know about long-term effects.
What the Results Show
The FMT group showed dramatically better results than the other two groups. At two weeks, patients receiving FMT had significantly higher microbial diversity—meaning a greater variety of different bacterial species in their gut—compared to those receiving only antibiotics or probiotics. The Chao1 index, a measure of bacterial diversity, was statistically significantly higher in the FMT group (p = 0.0125). Other diversity measures (Shannon and Simpson indices) showed similar trends favoring FMT, though these didn’t quite reach statistical significance (p = 0.06).
FMT also changed the types of bacteria present. The treatment increased beneficial Bacteroides bacteria while reducing harmful Enterobacteriaceae. This shift is important because Enterobacteriaceae includes potentially dangerous bacteria like E. coli that can cause infections. BugBase analysis—a computational tool that predicts whether bacteria are likely to be harmful—showed that FMT significantly reduced the pathogenic potential of the gut microbiota (p = 0.021), meaning the overall bacterial community became less likely to cause harm.
Interestingly, genetic analysis showed that FMT shifted patients’ gut bacteria to resemble their donor’s bacterial profile, confirming that the transplanted bacteria successfully established themselves. In contrast, the probiotics group showed minimal improvement compared to the control group, suggesting that the probiotic supplement used in this study was not effective at restoring gut diversity in this critically ill population.
The study measured inflammatory markers in the blood, though specific results weren’t detailed in the abstract. The fact that FMT reduced the pathogenic potential of gut bacteria suggests it may help reduce inflammation and infection risk, though this needs further investigation. The successful establishment of donor bacteria in FMT recipients indicates that the transplantation procedure itself was technically successful and that transplanted bacteria can survive and thrive in antibiotic-treated patients.
Previous research has shown that antibiotics cause severe dysbiosis (bacterial imbalance) in hospitalized patients, increasing infection risk and prolonging recovery. This study is among the first to directly compare FMT and probiotics in critically ill sepsis patients. Most prior FMT research has focused on other conditions like recurrent C. difficile infections. The finding that probiotics were ineffective in this population differs from some other studies, possibly because critically ill sepsis patients have more severe dysbiosis that simple probiotic supplements cannot overcome.
The sample size is small (40 patients total, with only 10 in each treatment group), making results preliminary. The study was conducted at a single hospital, so results may not apply everywhere. The treatment period was short (one week), and follow-up was only two weeks, so we don’t know if benefits persist longer. The study didn’t report detailed clinical outcomes like infection rates, hospital stay length, or mortality, which are ultimately what matters most for patients. The probiotic regimen used may not have been optimal—different probiotic formulations might produce different results. Finally, this was a pilot study designed to test feasibility, not to prove FMT works, so larger confirmatory studies are needed.
The Bottom Line
Based on this preliminary evidence, FMT appears more effective than probiotics for restoring gut bacteria in antibiotic-treated sepsis patients (moderate confidence level—this is early research). However, FMT is an invasive procedure with potential risks, so it should only be considered in specialized medical settings under doctor supervision. Standard probiotics, at least the regimen tested here, do not appear beneficial for this population. Anyone hospitalized with sepsis should discuss gut health restoration options with their medical team, as this research is too preliminary to guide individual treatment decisions.
This research is most relevant to critically ill sepsis patients receiving broad-spectrum antibiotics, their families, and intensive care physicians. It may also interest gastroenterologists and infectious disease specialists. People with mild infections or those taking antibiotics at home should not assume these findings apply to them, as sepsis is a severe condition requiring hospitalization. Healthy people considering probiotics for general wellness should not be discouraged by this study, which specifically examined a critically ill population.
In this study, improvements in gut bacteria diversity were measurable within two weeks. However, we don’t know how long benefits persist or when clinical improvements (like reduced infection risk or faster recovery) would become apparent. Patients should expect that any gut restoration treatment is part of a longer recovery process, not a quick fix.
Frequently Asked Questions
Is fecal microbiota transplantation safe for sepsis patients on antibiotics?
This pilot study of 40 patients suggests FMT is feasible in this population, with transplanted bacteria successfully establishing themselves. However, safety data is limited. FMT carries potential risks including infection transmission and should only be performed in specialized medical settings under physician supervision.
Do probiotics help restore gut bacteria after sepsis treatment?
In this 2026 study of 40 sepsis patients, the probiotic regimen tested showed minimal benefit compared to antibiotics alone. However, different probiotic formulations or dosages might produce different results. Talk with your doctor about whether probiotics are appropriate for your specific situation.
How long does it take to restore gut bacteria after antibiotics for sepsis?
This study measured improvements within two weeks using FMT. However, this is preliminary research with short follow-up. Complete gut restoration likely takes longer, and individual recovery varies. Your medical team can monitor your specific recovery timeline.
Can I use probiotics instead of FMT to recover from sepsis?
Based on this pilot study, FMT appeared more effective than the probiotic regimen tested for restoring gut diversity in sepsis patients. However, this is early research. Discuss all options with your intensive care team, as treatment decisions depend on your individual medical situation and available resources.
What bacteria does FMT restore in sepsis patients?
This study found FMT increased beneficial Bacteroides bacteria and reduced harmful Enterobacteriaceae. The transplanted bacteria shifted patients’ microbiomes toward their donor’s bacterial profile. These changes suggest FMT restores a more balanced, less pathogenic gut community in antibiotic-treated sepsis patients.
Want to Apply This Research?
- For sepsis patients in recovery, track daily stool consistency (using the Bristol Stool Scale: 1-7 rating), frequency of bowel movements, and any signs of infection (fever, increased inflammation markers if available). Record these daily for 4 weeks post-treatment to monitor gut recovery.
- If FMT is being considered as part of sepsis treatment, use the app to log pre- and post-FMT symptoms including bloating, digestive discomfort, energy levels, and infection signs. This creates a personal health record to share with your medical team and track individual response to treatment.
- Establish a 12-week tracking protocol: weekly stool health ratings, monthly inflammatory marker measurements if available through your doctor, and quarterly clinical assessments. Create a dashboard comparing your recovery timeline to typical sepsis recovery, with alerts for concerning changes that warrant medical contact.
This research is preliminary pilot study evidence and should not replace professional medical advice. Fecal microbiota transplantation is an invasive medical procedure with potential risks and should only be considered under direct physician supervision in appropriate medical settings. Sepsis is a life-threatening condition requiring immediate hospitalization and specialized medical care. If you or a loved one has sepsis, work with your intensive care team to determine appropriate treatments. This article is for educational purposes and does not constitute medical advice or treatment recommendations.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.